Replies to post #6181 on SiNtx Technologies Inc (SINT)

[BiotechValues]

Crappy management that's brought in lousy, below market financing deals, dilution, historically high cash burn rates, huge reverse splits, multiple delays with FDA approval, poor to non-existant IR (since not renewing IRTH communications and taking IR in-house), management that I know that reads this board...


Anything else?

Oh yea, they don't bother to pr an FDA approval in a timely manner.

So bad retail signing a petition to remove the CEO

http://www.ipetitions.com/petition/balsgottogo?utm_medium=email&utm_source=email&utm_campaign=Send%2Bto%2BFriend

And- no institutional involvement except for a crappy hedge fund or two... if you want to call that "institutional" participation.

You don't take a $40+ stock and run it down to .65 in two years unless you're a pathetic loser...and that's what management here is.

Too many distractions in Salt Lake City's underground gay and drug cultures for simple mormons to handle.


That said... they have an amazing product and if they announce the FDA approval, it will hit $2+ in a heartbeat.

Just my opinion....

[ClayTrader]

No it was not. It had a reverse split: https://claytrader.com/videos/what-is-a-reverse-split/